Ostrominski JW, Cho SMJ, Vaduganathan M, Honigberg MC. Cause-specific death in adults with type 1 diabetes and type 2 diabetes: Insights from the UK Biobank. Diabetes, obesity & metabolism. 2024. doi:10.1111/dom.16009Google ScholarDOIPubMed
Angelidi AM, Martinou EG, Karamanis DG. Metabolic-Bariatric Surgery Reduces Pancreatic Cancer Risk: A Meta-Analysis of Over 3.7 Million Adults, Independent of Type 2 Diabetes Status. Diabetes/metabolism research and reviews. 2024;40(7):e3844. doi:10.1002/dmrr.3844Google ScholarDOIPubMed
Guirette M, Sevilla-Gonzalez M, Balaguera M, Caballero AE. A nutrition-focused review of the interventions in US-living Latino communities with type II diabetes. Frontiers in nutrition. 2024;11:1418683. doi:10.3389/fnut.2024.1418683Google ScholarDOIPubMed
Martinez-Gonzalez MA, Planes FJ, Ruiz-Canela M, et al. Recent advances in precision nutrition and cardiometabolic diseases. Revista espanola de cardiologia (English ed.). 2024. doi:10.1016/j.rec.2024.09.003Google ScholarDOIPubMed
Liu S, Zhu J, Zhong H, et al. Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations. Diabetologia. 2024. doi:10.1007/s00125-024-06277-3Google ScholarDOIPubMed
Khanmohammadi S, Habibzadeh A, Kamrul-Hasan ABM, Schuermans A, Kuchay MS. Glucose-lowering drugs and liver-related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population-based studies. Diabetic medicine : a journal of the British Diabetic Association. 2024:e15437. doi:10.1111/dme.15437Google ScholarDOIPubMed
Windred DP, Burns AC, Rutter MK, et al. Personal light exposure patterns and incidence of type 2 diabetes: analysis of 13 million hours of light sensor data and 670,000 person-years of prospective observation. The Lancet regional health. Europe. 2024;42:100943. doi:10.1016/j.lanepe.2024.100943Google ScholarDOIPubMed
Mandla R, Schroeder P, Porneala B, et al. Polygenic scores for longitudinal prediction of incident type 2 diabetes in an ancestrally and medically diverse primary care physician network: a patient cohort study. Genome medicine. 2024;16(1):63. doi:10.1186/s13073-024-01337-0Google ScholarDOIPubMed
Guan D, Men Y, Bartlett A, et al. Central inhibition of HDAC6 re-sensitizes leptin signaling during obesity to induce profound weight loss. Cell metabolism. 2024;36(4):857-876.e10. doi:10.1016/j.cmet.2024.02.007Google ScholarDOIPubMed
García-Gavilán JF, Babio N, Toledo E, et al. Olive oil consumption, plasma metabolites, and risk of type 2 diabetes and cardiovascular disease. Cardiovascular diabetology. 2023;22(1):340. doi:10.1186/s12933-023-02066-1Google ScholarDOIPubMed